Title : Regression of advanced refractory ovarian cancer treated with iodine-131-labeled anti-CEA monoclonal antibody.

Pub. Date : 1997 Feb

PMID : 9025751






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 A complete clinical remission, using two cycles of 131I-labeled murine MN-14 anti-CEA monoclonal antibody (MAb), given intravenously, is reported in a patient with advanced ovarian cancer refractory to paclitaxel (Taxol) therapy. Iodine-131 carcinoembryonic antigen gene family Mus musculus